The burgeoning landscape of therapeutic interventions for weight disorders has witnessed considerable attention focused on GLP-3 analogues and, more recently, the dual GIP and GLP-3 receptor agonist retatrutide. While https://dawudhujf616305.wikijournalist.com/30439/glp_3_retatrutide_a_comparative_analysis